We are live on
!
Find out more
AC
Almitas Capital Portfolio holdings
AUM
$417M
1-Year Est. Return
22.81%
This Fund
S&P 500
This Quarter
Est. Return
+1.7%
1 Year Est. Return
+22.81%
3 Year Est. Return
+86.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$417M
AUM Growth
-$25.2M
(-5.7%)
Cap. Flow
-$24.7M
Cap. Flow
% of AUM
-5.92%
Top 10 Holdings %
Top 10 Hldgs %
52.38%
Holding
150
New
35
Increased
33
Reduced
22
Closed
21
Avg Time Held
2.7
quarters
Top 10 Avg Time Held
3.3
quarters
Top 20 Avg Time Held
2.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tortoise Energy Infrastructure Corp
TYG
|
+$7.43M |
| 2 |
ASA Gold and Precious Metals
ASA
|
+$6.48M |
| 3 |
Aberdeen Municipal Income Fund
MFM
|
+$4.77M |
| 4 |
iShares Core 60/40 Balanced Allocation ETF
AOR
|
+$4.76M |
| 5 |
Schwab US REIT ETF
SCHH
|
+$4.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amylyx Pharmaceuticals
AMLX
|
+$17.7M |
| 2 |
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
|
+$12.6M |
| 3 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$10.8M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$8.43M |
| 5 |
Design Therapeutics
DSGN
|
+$6.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.24% |
| 2 | Healthcare | 14.39% |
| 3 | Financials | 6.53% |
| 4 | Real Estate | 5.02% |
| 5 | Consumer Discretionary | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Fidelity Wise Origin Bitcoin Fund
FBTC
$15.4B
| $69.7M | 16.69% |
1,364,522
-172,115
| -11% | -$10.8M |
2024 Q3
7 quarters
|
|
2
BlackRock Municipal 2030 Target Term Trust
BTT
$1.38B
| $33.8M | 8.1% |
1,485,213
-800
| -0.1% | -$18.2K |
2024 Q2
8 quarters
|
|
|
3
ASA Gold and Precious Metals
ASA
$991M
| $32.7M | 7.84% |
629,121
+103,455
| +20% | +$6.48M |
2025 Q3
3 quarters
|
|
|
4
Amylyx Pharmaceuticals
AMLX
$3.37B
| $17.5M | 4.2% |
974,881
-1,147,716
| -54% | -$17.7M |
2024 Q2
8 quarters
|
|
|
5
Design Therapeutics
DSGN
$612M
| $14.9M | 3.56% |
1,026,893
-503,442
| -33% | -$6.28M |
2023 Q4
10 quarters
|
|
6
PIMCO Dynamic Income Strategy Fund
PDX
$916M
| $11.4M | 2.74% |
549,495
+8,003
| +1% | +$169K |
2025 Q4
2 quarters
|
|
7
Cornerstone Total Return Fund
CRF
$1.06B
| $11.3M | 2.7% |
1,572,309
+456,961
| +41% | +$3.28M |
2025 Q4
2 quarters
|
|
8
Cannae Holdings
CNNE
$682M
| $10.7M | 2.56% |
741,318
| – | – |
2025 Q1
5 quarters
|
|
9
NYLIM CBRE Global Infrastructure Megatrends Term Fund
MEGI
$728M
| $8.47M | 2.03% |
557,462
+241,329
| +76% | +$3.66M |
2025 Q4
2 quarters
|
|
10
Lyell Immunopharma
LYEL
$184M
| $8.17M | 1.96% |
581,407
+3,600
| +0.6% | +$65.2K |
2024 Q4
6 quarters
|
|
11
BlackRock Health Sciences Trust II
BMEZ
$1.01B
| $7.78M | 1.87% |
507,095
+700
| +0.1% | +$10.1K |
2025 Q4
2 quarters
|
|
12
AN2 Therapeutics
ANTX
$136M
| $7.11M | 1.7% |
1,469,129
-10,000
| -0.7% | -$43K |
2024 Q4
6 quarters
|
|
|
13
Tortoise Energy Infrastructure Corp
TYG
$1.03B
| $6.94M | 1.66% |
+161,872
| New | +$7.43M |
2026 Q2
0 quarters
|
|
14
Pimco California Municipal Income Fund
PCQ
$148M
| $6.37M | 1.53% |
710,604
+93,589
| +15% | +$822K |
2025 Q1
5 quarters
|
|
15
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$340M
| $6.09M | 1.46% |
326,907
+238,355
| +269% | +$4.22M |
2026 Q1
1 quarter
|
|
16
ALX Oncology
ALXO
$135M
| $6.08M | 1.46% |
2,938,431
-235,403
| -7% | -$421K |
2024 Q4
6 quarters
|
|
17
FS Specialty Lending Fund
FSSL
$868M
| $5.99M | 1.44% |
537,295
+268,485
| +100% | +$3.17M |
2025 Q4
2 quarters
|
|
18
PGIM Short Duration High Yield Opportunities Fund
SDHY
$375M
| $5.98M | 1.43% |
364,674
+185,753
| +104% | +$2.98M |
2022 Q4
14 quarters
|
|
19
Cornerstone Strategic Value Fund
CLM
$2.07B
| $5M | 1.2% |
661,789
+219,775
| +50% | +$1.65M |
2026 Q1
1 quarter
|
|
|
20
Aberdeen Municipal Income Fund
MFM
$206M
| $4.94M | 1.18% |
+878,531
| New | +$4.77M |
2026 Q2
0 quarters
|
|
|
21
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.95B
| $4.86M | 1.16% |
+69,946
| New | +$4.76M |
2026 Q2
0 quarters
|
|
|
22
Schwab US REIT ETF
SCHH
$10.8B
| $4.7M | 1.13% |
+198,600
| New | +$4.63M |
2026 Q2
0 quarters
|
|
23
BNY Mellon Strategic Municipal Bond Fund
DSM
$257M
| $4.66M | 1.12% |
757,999
-168,302
| -18% | -$1.02M |
2024 Q4
6 quarters
|
|
24
Liberty All-Star Equity Fund
USA
$1.83B
| $4.64M | 1.11% |
798,342
+402,857
| +102% | +$2.32M |
2025 Q4
2 quarters
|
|
25
Japan Smaller Capitalization Fund
JOF
$353M
| $4.55M | 1.09% |
386,375
-16,581
| -4% | -$189K |
2022 Q1
17 quarters
|
|
Similar funds
CWA
SCM
EWM
RA
CIM
MWM
VA
CWM
Almitas Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Almitas Capital held 150 positions worth $417M, down 5.7% from $443M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Almitas Capital withdrew a net $24.7M in Q2 2026, closing 21 positions and reducing 22 holdings. Its most notable exit was Nuveen Pennsylvania Quality Municipal Income Fund, an estimated $12.6M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, up from 66% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Almitas Capital opened a new position in Tortoise Energy Infrastructure Corp worth $6.94M.
- Almitas Capital's largest Q2 2026 buy was Tortoise Energy Infrastructure Corp: 161,872 shares worth $6.94M.
- Almitas Capital added most to ASA Gold and Precious Metals in Q2 2026, an estimated $6.48M increase.
- Almitas Capital's biggest Q2 2026 reduction was Amylyx Pharmaceuticals, cutting an estimated $17.7M.
- Almitas Capital fully exited Nuveen Pennsylvania Quality Municipal Income Fund in Q2 2026, selling an estimated $12.6M.
- Almitas Capital's ten largest holdings make up 52% of its $417M portfolio in Q2 2026.
- Almitas Capital opened 35 new positions and closed 21 in Q2 2026.
- Almitas Capital's portfolio value fell 5.7% quarter-over-quarter to $417M.
Based on Almitas Capital's 13F filing for Q2 2026, filed 17 Aug 2026.